Smart Infusion Pumps Global Market Report 2025

The smart infusion pumps market size has grown strongly in recent years. It will grow from $8.1 billion in 2024 to $8.88 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. This growth during the historical period was driven by factors such as the increasing prevalence of chronic conditions, rising demand for accurate medication dosing, a surge in hospital admissions, growing emphasis on patient safety, supportive regulatory frameworks for innovation in medical devices, and the expansion of smart healthcare technologies.

The smart infusion pumps market size is expected to see strong growth in the next few years. It will grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. Key drivers of this projected growth include greater demand for electronic health record (EHR) integration, the increasing use of cloud-based platforms for managing drug libraries, rising emphasis on tailored drug delivery, expanding use in home-based healthcare, heightened automation to minimize medication errors, and broader deployment for chronic disease treatments. Leading trends expected in this period involve the implementation of cloud-connected drug libraries, advanced wireless features, innovations in cassette-based infusion systems, AI-driven dosage optimization, live remote monitoring capabilities, seamless EHR interoperability, and miniaturization for enhanced portability and outpatient care.

The rise in chronic diseases is expected to drive the growth of the smart infusion pumps market in the coming years. Chronic diseases are long-term conditions that develop over time and typically require ongoing care or management. The growing prevalence of such conditions is largely attributed to increasingly sedentary lifestyles, which contribute to obesity, diabetes, and cardiovascular disorders. Smart infusion pumps play a critical role in managing chronic diseases by delivering precise and automated doses of medication, thereby reducing human error and improving long-term treatment outcomes. For example, in April 2025, the International Diabetes Federation (IDF), a Belgium-based non-profit organization, reported that nearly 589 million adults aged 20-79 are living with diabetes worldwide, a figure projected to increase significantly to 853 million by 2050. This rising incidence of chronic disease is thus fueling the demand for smart infusion pumps.

Companies operating in the smart infusion pumps market are prioritizing innovation, particularly through the development of cassette-based infusion pumps that aim to enhance medication delivery accuracy, improve patient safety, and streamline clinical workflows. Cassette-based infusion pumps use disposable cassettes to administer fluids or medications with high precision. For instance, in August 2023, ICU Medical Inc., a U.S.-based medical technology company, received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its Plum Duo infusion pump, which is integrated with the cloud-based LifeShield software. The pump features dual-channel delivery for simultaneous administration of two compatible intravenous therapies, thereby improving workflow efficiency and patient care. It also incorporates advanced drug library integration and automated programming to minimize medication errors. The LifeShield software enhances the pump with real-time monitoring, data-driven insights, and clinical decision support, which together ensure higher infusion safety and adherence to hospital protocols.

In September 2023, Abbott Laboratories, a U.S.-based pharmaceutical company, acquired Bigfoot Biomedical for an undisclosed sum. This acquisition is intended to strengthen Abbott’s diabetes care offerings by integrating Bigfoot Biomedical’s smart insulin management technology with its FreeStyle Libre continuous glucose monitoring system. This integration aims to deliver a more comprehensive and connected solution for patients who require insulin. Bigfoot Biomedical Inc. is a U.S.-based company specializing in the development of smart infusion pumps.

Major players in the smart infusion pumps market are F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Medtronic plc, Becton Dickinson and Company (BD), Boston Scientific Corporation, Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Moog Inc., ICU Medical Inc., Insulet Corporation, Avanos Medical Inc., JMS Co. Ltd., Vygon SA, B. Braun Melsungen AG, Med One Capital Funding LLC, Eitan Group, Heka Healthcare B.V., PROMECON GmbH, and Micrel Medical Devices SA.

North America was the largest region in the smart infusion pumps market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smart infusion pumps report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smart infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Smart infusion pumps are sophisticated upgrades of conventional infusion pumps, equipped with software and sometimes integrated connectivity features aimed at improving the safety and efficiency of medication administration. These devices come with advanced functionalities such as drug libraries, alert systems, and other intelligent technologies that help minimize human errors and enhance the precision of drug delivery.

The primary categories of smart infusion pumps include large volumetric infusion pumps, patient-controlled analgesia pumps, syringe infusion systems, electronic ambulatory infusion systems, implantable infusion systems, MRI-compatible IV infusion pump systems, disposable elastomeric infusion systems, and others. Among these, large volumetric infusion pumps are specifically engineered to administer high volumes of fluids, medications, or nutrients into the patient’s bloodstream at regulated flow rates. These devices utilize various technologies such as digital infusion systems, smart pump platforms, wireless connectivity, traditional infusion mechanisms, and closed-loop controls. They are widely used across multiple medical disciplines such as oncology or chemotherapy, pediatrics or neonatology, gastroenterology, hematology, diabetes care, and others, and are employed in diverse healthcare environments, including hospitals, ambulatory surgical centers, home healthcare, specialty clinics, and more.

The smart infusion pumps market research report is one of a series of new reports that provides smart infusion pumps market statistics, including the smart infusion pumps industry global market size, regional shares, competitors with the smart infusion pumps market share, detailed smart infusion pumps market segments, market trends, and opportunities, and any further data you may need to thrive in the smart infusion pumps industry. This smart infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart infusion pumps market includes revenues earned by entities by providing services such as equipment installation, maintenance, software updates, user training, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart infusion pumps market also includes sales of infusion pump units, syringes, pole clamps, and mounting hardware. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.